Lymphoblastic Lymphoma - 26 Studies Found Withdrawn : An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase) : : 2024-05-21 Recruiting : Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia : T-cell Type Acute Leukemia-Precursor T-lymphoblastic Lymphoma/Leukaemia : 2016-12-19 : Drug: Isatuximab SAR650984 Pha Completed : A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy : Acute Lymphoblastic Leukemia Lymphoblastic Lymphoma : 2012-06-25 : Drug: asparaginase Erwinia chrysanthemi Recruiting : Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults : Acute Lymphoblastic Leukemia Lymphoblastic Lymphoma : 2015-08-04 : Drug: Velcade 4 doses of study Recruiting : Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma : Adult B Lymphoblastic Lymphoma Childhood B Acute Lymphoblastic : 2010-08-27 : Drug: Cyclophosphamide Given I RECRUITING : A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL) : Lymphoblastic Lymphoma : 2024-05-21 : A single dose of BEAM-201 administered by IV following one of two lymphodepletion regimens <<< Previous